Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Webcasts

Mitigating Pharmaceutical Production Risks Using Hot Water for Injection and Pure Steam

January 12, 2024

Webinar Date/Time: Wed, Feb 7, 2024 10:30 AM CET (4:30 AM EST)

A Platform for mRNA Platforms

January 11, 2024

Regulators from around the world will gather to help shape the mRNA and RNA therapeutics landscape at an exceptional April 2024 Washington, D.C. convocation.

Relative Bioavailability Trial of Nanotechnology-Enhanced Enzalutamide is Underway

January 10, 2024

Nanoform has completed the First Subject First Visit in a trial evaluating the relative bioavailability of its nanotechnology-enhanced enzalutamide.

GSK to Acquire Aiolos Bio, Expands Respiratory Portfolio

January 09, 2024

In a deal worth up to $1.4 billion, GSK aims to acquire Aiolos Bio and gain an expanded pipeline of biologic-based respiratory therapeutic candidates.

Webcasts

Zerion Pharma R&D Day – Dispersome® Drug Formulation Platform

January 08, 2024

Webinar Date/Time: Tue, Jan 30, 2024 9:00 AM EST

Webcasts

Making the Grade: The Importance of Using the Correct Excipient Grade in Drug Products

January 08, 2024

Webinar Date/Time: Thu, Jan 25, 2024 11:00 AM EST

Webcasts